User menu

Characteristics and Determinants of Partial Remission in Children with Type 1 Diabetes Using the Insulin-Dose-Adjusted A1C Definition

Bibliographic reference Pecheur, Aurore ; BARREA, Thierry ; Vandooren, Valérie ; Beauloye, Véronique ; Robert, Annie ; et. al. Characteristics and Determinants of Partial Remission in Children with Type 1 Diabetes Using the Insulin-Dose-Adjusted A1C Definition. In: Journal of Diabetes Research, Vol. 2014, no.ID 851378,, p. 1-7 (2014)
Permanent URL
  1. Erratum, 10.2337/db12-er06a
  2. Van Belle T. L., Coppieters K. T., Von Herrath M. G., Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies, 10.1152/physrev.00003.2010
  3. Hramiak I. M., Dupre J., Finegood D. T., Determinants of Clinical Remission in Recent-Onset IDDM, 10.2337/diacare.16.1.125
  4. Mortensen H. B., Hougaard P., Swift P., Hansen L., Holl R. W., Hoey H., Bjoerndalen H., de Beaufort C., Chiarelli F., Danne T., Schoenle E. J., Aman J., , New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes, 10.2337/dc08-1987
  5. Weir Gordon C., Bonner-Weir Susan, Islet β cell mass in diabetes and how it relates to function, birth, and death : Islet β cell mass in diabetes, 10.1111/nyas.12031
  6. Staeva Teodora P., Chatenoud Lucienne, Insel Richard, Atkinson Mark A., Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials, 10.2337/db12-0562
  7. Steffes M. W., Sibley S., Jackson M., Thomas W.,  -Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications Trial, 10.2337/diacare.26.3.832
  8. Pediatric Diabetes, 10, 1 (2009)
  9. Neylon O. M., White M., O´Connell M. A., Cameron F. J., Insulin-dose-adjusted HbA1c-defined partial remission phase in a paediatric population-when is the honeymoon over?, 10.1111/dme.12097
  10. Bowden Sasigarn A, Duck Mary M, Hoffman Robert P, Young children (<5 yr) and adolescents (>12 yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor, 10.1111/j.1399-5448.2008.00376.x
  11. Abdul-Rasoul Majedah, Habib Hessa, Al-Khouly Maha, 'The honeymoon phase' in children with type 1 diabetes mellitus: frequency, duration, and influential factors, 10.1111/j.1399-543x.2006.00155.x
  12. Pozzilli P., Manfrini S., Buzzetti R., Lampeter E., Leeuw I.De., Iafusco D., Prisco M., Ionescu-Tirgoviste C., Kolouskovà S., Linn T., Ludvigsson J., Madàcsy L., Mrozikiewicz A.Seremak., Mrozikiewicz P.M., Podar T., Vavrinec J., Vialettes B., Visalli N., Yilmaz T., Browne P.D., Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study, 10.1016/j.diabres.2004.10.001
  13. Dost A., Herbst A., Kintzel K., Haberland H., Roth C., Gortner L., Holl R., Shorter Remission Period in Young Versus Older Children with Diabetes Mellitus Type 1, 10.1055/s-2007-948214
  14. Martin S., Pawlowski B., Greulich B., Ziegler A. G., Mandrup-Poulsen T., Mahon J., Natural Course of Remission in IDDM During 1st yr After Diagnosis, 10.2337/diacare.15.1.66
  15. Hathout E. H., Hartwick N., Fagoaga O. R., Colacino A. R., Sharkey J., Racine M., Nelsen-Cannarella S., Mace J. W., Clinical, Autoimmune, and HLA Characteristics of Children Diagnosed With Type 1 Diabetes Before 5 Years of Age, 10.1542/peds.111.4.860
  16. Komulainen J., Kulmala P., Savola K., Lounamaa R., Ilonen J., Reijonen H., Knip M., Akerblom H. K., Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group, 10.2337/diacare.22.12.1950
  17. Akirav E., Kushner J. A., Herold K. C.,  -Cell Mass and Type 1 Diabetes: Going, Going, Gone?, 10.2337/db07-1817
  18. Effect of Intensive Therapy on Residual β-Cell Function in Patients with Type 1 Diabetes in the Diabetes Control and Complications Trial : A Randomized, Controlled Trial, 10.7326/0003-4819-128-7-199804010-00001
  19. Ziegler Anette G., Rewers Marian, Simell Olli, Simell Tuula, Lempainen Johanna, Steck Andrea, Winkler Christiane, Ilonen Jorma, Veijola Riitta, Knip Mikael, Bonifacio Ezio, Eisenbarth George S., Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children, 10.1001/jama.2013.6285
  20. VanBuecken Dana E., Greenbaum Carla J., Residual C-peptide in type 1 diabetes: what do we really know? : Residual C-peptide in T1D, 10.1111/pedi.12135